Receiving reports that 15-18 age group being given vaccine other than Covaxin: Bharat Biotech

PTI

Updated At : 01:54 AM Jan 19, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Hyderabad, January 18

Bharat Biotech on Tuesday said it is receiving several reports that children in the age group 15 to 18 are being administered Covid-19 vaccine other than Covaxin.

Requesting the health workers to be vigilant and ensure that only Covaxin is administered to that particular age group, Bharat Biotech in a twitter post said its vaccine is the only approved Covid-19 jab to be administered to children in the age group between 15 and 18.

“We have received several additional reports of individuals in the 15-18 year age group being administered unapproved Covid-19 vaccines,” the company said.

Covaxin received approval based on thorough clinical trial evaluation for safety and immunogenicity in the 2-18 years age group. Currently it is the only Covid-19 vaccine in India approved for children, it added.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles